Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

GCK Activators

GCK activators pertain to a distinct class of chemical compounds that specifically engage with and activate glucokinase (GCK), an enzyme pivotal in the regulation of glucose metabolism in the body. Glucokinase functions as a glucose sensor and acts as a key player in maintaining glucose homeostasis. It catalyzes the initial step of glycolysis in the liver, which involves the conversion of glucose to glucose-6-phosphate (G6P). This enzyme operates with a substrate concentration closely mirroring the physiological glucose levels, which means that even slight changes in glucose concentration can influence its activity. The unique kinetic properties of GCK distinguish it from other hexokinase isoforms in the body. GCK activators, thus, modulate this enzyme's activity by binding to it and enhancing its affinity for glucose. By adjusting the responsiveness of GCK to glucose, these activators can manipulate the rate of glucose utilization.

The molecular design and architecture of GCK activators are often underlined by their ability to allosterically modulate the enzyme. Instead of interacting with the active site where the substrate binds, allosteric modulators affect enzyme activity by binding to a separate regulatory site. This kind of interaction changes the enzyme's conformation, enhancing or inhibiting its activity. In the context of GCK activators, allosteric binding generally augments the enzyme's functionality, facilitating glucose phosphorylation. Several GCK activators possess diverse chemical structures, demonstrating the array of possible interaction points and mechanisms through which they influence the enzyme's performance. The intrinsic biochemistry of these compounds offers fascinating insights into the world of molecular modulation and highlights the complexities of metabolic regulation at the cellular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GKA50

851884-87-2sc-489933
5 mg
$142.00
(0)

A compound that showed potential in research studies for its glucose-lowering effect.

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione

sc-501137
25 mg
$380.00
(0)

A compound that has been studied for its glucose-lowering effect in research models.

Dapagliflozin

461432-26-8sc-364481
sc-364481A
sc-364481B
5 mg
50 mg
1 g
$117.00
$428.00
$1051.00
6
(1)

While primarily known as an SGLT2 inhibitor, some studies suggest it may also possess GCK-activating properties.